View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
May 15, 2020

Majority of Covid-19 clinical trials showing ‘encouraging’ signs, says analyst

By Jamie Bell

The majority of clinical trials involving Covid-19 vaccines or treatments are showing “encouraging” results, says an analyst.

Of the 21 ongoing coronavirus trials that have reported interim results, 16 have produced positive indications early on, according to analytics firm GlobalData.

Some 69% of these clinical trials are currently in the early stages — either Phase I or Phase II — with US biotech firm Gilead Sciences’ remdesivir drug being the main exception having moved into Phase III testing in late-February.

Read the full article here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena